OTCPK:PLLW.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. More Details


Snowflake Analysis

Flawless balance sheet with weak fundamentals.

Share Price & News

How has Polarean Imaging's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: PLLW.F has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

PLLW.F

-2.5%

US Medical Equipment

-3.1%

US Market


1 Year Return

n/a

PLLW.F

14.6%

US Medical Equipment

12.7%

US Market

Return vs Industry: Insufficient data to determine how PLLW.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how PLLW.F performed against the US Market.


Shareholder returns

PLLW.FIndustryMarket
7 Day0%-2.5%-3.1%
30 Day0%-0.06%-2.9%
90 Dayn/a13.9%8.2%
1 Yearn/a15.6%14.6%15.3%12.7%
3 Yearn/a71.4%67.0%37.8%28.5%
5 Yearn/a149.1%130.4%90.9%69.4%

Price Volatility Vs. Market

How volatile is Polarean Imaging's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Polarean Imaging undervalued compared to its fair value and its price relative to the market?

13.81x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate PLLW.F's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate PLLW.F's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: PLLW.F is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.

PE vs Market: PLLW.F is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate PLLW.F's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: PLLW.F is overvalued based on its PB Ratio (13.8x) compared to the US Medical Equipment industry average (3.7x).


Next Steps

Future Growth

How is Polarean Imaging forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

26.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Polarean Imaging has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Polarean Imaging performed over the past 5 years?

-33.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: PLLW.F is currently unprofitable.

Growing Profit Margin: PLLW.F is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: PLLW.F is unprofitable, and losses have increased over the past 5 years at a rate of 33% per year.

Accelerating Growth: Unable to compare PLLW.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PLLW.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.2%).


Return on Equity

High ROE: PLLW.F has a negative Return on Equity (-132.97%), as it is currently unprofitable.


Next Steps

Financial Health

How is Polarean Imaging's financial position?


Financial Position Analysis

Short Term Liabilities: PLLW.F's short term assets ($3.2M) exceed its short term liabilities ($1.9M).

Long Term Liabilities: PLLW.F's short term assets ($3.2M) exceed its long term liabilities ($559.3K).


Debt to Equity History and Analysis

Debt Level: PLLW.F is debt free.

Reducing Debt: PLLW.F currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: PLLW.F has sufficient cash runway for 5 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: PLLW.F is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.


Next Steps

Dividend

What is Polarean Imaging current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate PLLW.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PLLW.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if PLLW.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PLLW.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of PLLW.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.3yrs

Average board tenure


CEO

Clairis Hullihen (67 yo)

no data

Tenure

US$322,639

Compensation

Mr. Clairis Richard Hullihen serves as the Chief Executive Officer of Polarean Imaging Plc and has been its Director since May 30, 2017. Mr. Hullihen has many years in medical imaging experience. He began ...


CEO Compensation Analysis

Compensation vs Market: Clairis's total compensation ($USD322.64K) is below average for companies of similar size in the US market ($USD601.89K).

Compensation vs Earnings: Clairis's compensation has increased whilst the company is unprofitable.


Board Members

NamePositionTenureCompensationOwnership
Clairis Hullihen
CEO & Directorno dataUS$322.64k1.81%
$ 1.6m
Bastiaan Driehuys
Founder3.33yrsUS$59.04k7.58%
$ 6.8m
Kenneth West
COO & Director3.33yrsUS$211.88k0.29%
$ 263.5k
Cyrille Petit
Non-Executive Director0.25yrno data0.22%
$ 193.9k
Jonathan Allis
Independent Chairman0.58yrUS$54.04k1.5%
$ 1.3m
Juergen Laucht
Non-Executive Director3.33yrsUS$64.04kno data

3.3yrs

Average Tenure

60yo

Average Age

Experienced Board: PLLW.F's board of directors are considered experienced (3.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 59.5%.


Top Shareholders

Company Information

Polarean Imaging plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Polarean Imaging plc
  • Ticker: PLLW.F
  • Exchange: OTCPK
  • Founded: 2016
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: UK£70.396m
  • Listing Market Cap: UK£89.663m
  • Shares outstanding: 161.83m
  • Website: https://www.polarean.com

Number of Employees


Location

  • Polarean Imaging plc
  • 2500 Meridian Parkway
  • Suite 175
  • Durham
  • North Carolina
  • 27713
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
POLXAIM (London Stock Exchange AIM Market)YesOrdinary SharesGBGBPMar 2018
PLLW.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDMar 2018

Biography

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. The company engages in the development and commercial ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/23 06:22
End of Day Share Price2020/07/01 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.